KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesSales of Property, Plant and EquipmentShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Amneal Pharmaceuticals (AMRX) Dividends Paid - Common (2017 - 2018)

Historic Dividends Paid - Common for Amneal Pharmaceuticals (AMRX) over the last 2 years, with Q4 2018 value amounting to $2000.0.

  • Amneal Pharmaceuticals' Dividends Paid - Common fell 9999.0% to $2000.0 in Q4 2018 from the same period last year, while for Sep 2019 it was $2000.0, marking a year-over-year decrease of 9999.9%. This contributed to the annual value of $183.0 million for FY2018, which is 5123.45% down from last year.
  • Per Amneal Pharmaceuticals' latest filing, its Dividends Paid - Common stood at $2000.0 for Q4 2018, which was down 9999.0% from $153.0 million recorded in Q2 2018.
  • In the past 5 years, Amneal Pharmaceuticals' Dividends Paid - Common ranged from a high of $153.0 million in Q2 2018 and a low of $2000.0 during Q4 2018